J8700 Temozolomide
Also known as: Temodar, Oral temozolomide
Temozolomide administered orally; an alkylating agent prodrug used for primary malignant brain tumors and melanoma.
In Plain Language
Brain tumor treatment pill; Chemotherapy medication
Clinical Context
Used for glioblastoma multiforme and other primary brain tumors. Also used for melanoma. Good central nervous system penetration.
RVU Information
CPT J8700 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J8700?
CPT J8700 (Temozolomide) is a J Codes (Drugs) code. Temozolomide administered orally; an alkylating agent prodrug used for primary malignant brain tumors and melanoma.
How is J8700 administered?
CPT J8700 is administered by a healthcare provider, typically via injection or infusion. Used for glioblastoma multiforme and other primary brain tumors. Also used for melanoma. Good central nervous system penetration. It is used by Oncology, Neurology, Neurosurgery.
When is CPT J8700 used?
Used for glioblastoma multiforme and other primary brain tumors. Also used for melanoma. Good central nervous system penetration.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.